Hossam Abdel-Ghaffar, the spokesman for the Ministry of Health and Population, announced that mRNA technology has joined the vaccine manufacturing system inside Egypt as part of the program to address the spread of coronavirus.
The new technology came after the World Health Organization agreed to grant Egypt, in addition to 5 African countries, approval to manufacture advanced COVID-19 vaccines.
What do we know about mRNA technology?
According to the US Center for Disease Control and Prevention, vaccines manufactured using this technology train cells how to make a protein that triggers an immune response themselves.
Like all other vaccines, mRNA vaccines benefit vaccinators by giving them protection from diseases such as the coronavirus without risking serious potential consequences for the disease.
mRNA vaccines, when received, work to enter muscle cells and direct the cells’ machinery to produce a harmless piece of the spike protein.
As this protein was found on the surface of the virus that causes corona, and then our cells disassemble and remove the disease-causing cells.
The immune system then realizes that the protein does not belong to it: triggering our immune system to produce antibodies and activate other immune cells to fight what it thinks is an infection.
The end of the process gives the body experience on how to fight future infections.
The Center for Disease Control recommends that people who receive a vaccine made through this technology get two identical doses the first and second time.
As for the booster dose, it is not required to receive an identical dose to the previous two doses.
1. mRNA vaccines do not use the live virus that causes coronavirus, and cannot cause infection with the virus or any other virus.
2. These vaccines never enter the cell nucleus where our DNA is so they cannot change or affect our genes.
3. Spike protein resulting from using mRNA vaccines may remain in the body for up to a few weeks.
4. The newly made technology has been studied over several decades